Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed. This appears to be a site version update with no impact on the study details or data.
    Difference
    0.1%
    Check dated 2026-03-19T06:10:31.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:34:32.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision history updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-11T11:37:04.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 in the page metadata, with no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:16:28.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Changes are minor UI/footer and metadata updates (glossary toggle, QC criteria label, FEAR Act references, and version string) that do not affect core study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:01:31.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4, and no clinical study information or user-facing functionality is affected.
    Difference
    0.1%
    Check dated 2026-01-14T03:04:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.